Mary C. White, ScD
Mary C. White, ScD, has broad experience in the development, conduct, and translation of population-based health research. In her current position as Chief of the Epidemiology and Applied Research Branch in CDC’s Division of Cancer Prevention and Control, Dr. White directs a program of applied research and science dissemination to support CDC programs and partners and address national priorities in cancer prevention and control. She oversees a portfolio of intramural and extramurally funded projects involving epidemiology, disease and risk factor surveillance, behavioral science, economics, and health services research. Her multi-disciplinary team contributes data and scientific expertise on strategies to reduce cancer risk, the quality and appropriate use of cancer screening, the cost and cost-effectiveness of cancer control programs, health and wellness after a cancer diagnosis (cancer survivorship), and efforts to address cancer health disparities and advance health equity.
Dr. White has published and lectured widely on topics related to the control of asthma, cancer, and other chronic diseases, the risks associated with exposure to air pollution and hazardous substances, and the interpretation of scientific evidence for public health. While at CDC, Dr. White has received numerous awards for both scientific achievement and leadership in management, including the Secretary’s Award for Distinguished Service and the HHS Award for Excellence in Management.
Dr. White has a Master of Public Health (MPH) from the University of Michigan School of Public Health, a Doctor of Science (ScD) in epidemiology and occupational health from the Harvard School of Public Health, and a Master of Fine Arts (MFA) in narrative media writing from the Grady College of Journalism and Mass Communication at the University of Georgia.
A full list of Dr. White’s publications is available at Google Scholar.
Selected publications first-authored by Dr. White include—
- 2022 Risk of clear-cell adenocarcinoma of the vagina and cervix among US women with potential exposure to diethylstilbestrol in utero.
- 2020 An expanded agenda for the primary prevention of breast cancer: charting a course for the future.
- 2019 Cancer risk among older adults: time for cancer prevention to go silver.
- 2018 Factors associated with breast MRI use among women with a family history of breast cancer.
- 2017 The history and use of cancer registry data by public health cancer control programs in the United States.
- 2017 Cervical cancer screening and incidence by age: unmet needs near and after the stopping age for screening.
- 2017 Prevalence of modifiable cancer risk factors among U.S. adults aged 18—44 years.
- 2016 Labeling cancer risk factors as lifestyle limits prevention activities across the life span.
- 2015 Public health’s future role in cancer survivorship.
- 2015 Preventing premature deaths from breast and cervical cancer among underserved women in the United States: insights gained from a national cancer screening program.
- 2014 Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States.
- 2014 Age and cancer risk: a potentially modifiable relationship.
- 2013 Cancer prevention for the next generation.
Dr. White offers her perspective in the in the following blog posts—